Mapping dopaminergic projections in the human brain with resting-state fMRI
- Radboud University Medical Centre, Netherlands
- Institute of Biomedicine of Seville (IBiS), Spain
- Radboud University Medical Center, Netherlands
Abstract
The striatum receives dense dopaminergic projections making it a key region of the dopaminergic system. Its dysfunction has been implicated in various conditions including Parkinson's disease (PD) and substance use disorder. However, the investigation of dopamine-specific functioning in humans is problematic as current MRI approaches are unable to differentiate between dopaminergic and other projections. Here, we demonstrate that 'connectopic mapping' -a novel approach for characterizing fine-grained, overlapping modes of functional connectivity- can be used to map dopaminergic projections in striatum. We applied connectopic mapping to resting-state functional MRI data of the Human Connectome Project (population cohort; N=839) and selected the second-order striatal connectivity mode for further analyses. We first validated its specificity to dopaminergic projections by demonstrating a high spatial correlation (r=0.884) with dopamine transporter availability -a marker of dopaminergic projections- derived from DaT SPECT scans of 209 healthy controls. Next, we obtained the subject-specific second-order modes from 20 controls, and 39 PD patients scanned under placebo and under dopamine replacement therapy (L-DOPA), and show that our proposed dopaminergic marker tracks PD diagnosis, symptom severity and sensitivity to L-DOPA. Finally, across 30 daily alcohol users and 38 daily smokers, we establish strong associations with self-reported alcohol and nicotine use. Our findings provide evidence that the second-order mode of functional connectivity in striatum maps onto dopaminergic projections, tracks inter-individual differences in PD symptom severity and L-DOPA sensitivity, and exhibits strong associations with levels of nicotine and alcohol use, thereby offering a new biomarker for dopamine-related (dys)function in the human brain.
Data availability
We made use of publicly available data from the Human Connectome Project (HCP) dataset, from publicly available data from the Parkinson Progression Marker Initiative (PPMI) dataset, and from a local PD dataset that was part of a clinical trial.See https://www.humanconnectome.org/study/hcp-young-adult/document/1200-subjects-data-release for access to the HCP data. The subject identifiers from the HCP dataset used in our first analysis can be found in Appendix 2 - Table 4. Please note that the subject identifiers from the subset of HCP subjects included in the nicotine-use and alcohol-use analyses cannot be provided, since the access to information about substance use is restricted. For more information about applying to get access to the HCP restricted data and for the HCP restricted data use terms see: https://www.humanconnectome.org/study/hcp-young-adult/document/wu-minn-hcp-consortium-restricted-data-use-terms.For access to the PPMI dataset, see https://www.ppmi-info.org/access-data-specimens/download-data. The subject identifiers from the PPMI dataset used in our analyses can be found in Appendix 2 - Tables 5 and 6.All derived and anonymized individual data from our local PD dataset are available at the Donders Repository: https://data.donders.ru.nl/.The code used for the connectopic mapping procedure in all three datasets is available at the following Github repository: https://github.com/koenhaak/congrads.In addition, for supplementary analyses, we further used PET scans available in the JuSpace Toolbox: https://github.com/ juryxy/JuSpace.
-
The WU-Minn human connectome project: an overview.Human Connectome Project, see Appendix 2 - Table 4.
-
The parkinson progression marker initiative (PPMI)Parkinson Progression Marker Initiative, see Appendix 2 - Tables 5 and 6.
Article and author information
Author details
Marianne Oldehinkel
Funding
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Vidi Grant No. 864-12-004)
- Christian F Beckmann
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Vici Grant No. 17854)
- Christian F Beckmann
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Vidi Grant No. 016.156.415)
- Andre F Marquand
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Veni Grant No. 016.171.068)
- Koen V Haak
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Veni Grant No. 91617077)
- Rick Helmich
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-CAS Grant No. 012-200-013)
- Christian F Beckmann
ZonMw (Rubicon Grant No. 452172019)
- Marianne Oldehinkel
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: All participants from whom data was used in this manuscript, provided written informed consent (and consent to publish) according to the declaration of Helsinki. For the HCP dataset ethical approval was given by the Washington University Institutional Review Board (IRB), for the PPMI dataset ethical approval was obtained locally at each of the participating sites, and for our local PD dataset ethical approval was obtained from the local ethical committee (Commissie Mensgebonden Onderzoek MO Arnhem Nijmegen, CMO 2014/014).
Copyright
© 2022, Oldehinkel et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 5,513
- views
-
- 598
- downloads
-
- 21
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Mapping dopaminergic projections in the human brain with resting-state fMRI
eLife 11:e71846.
https://doi.org/10.7554/eLife.71846
Further reading
-
- Medicine
- Neuroscience
The advent of midazolam holds profound implications for modern clinical practice. The hypnotic and sedative effects of midazolam afford it broad clinical applicability. However, the specific mechanisms underlying the modulation of altered consciousness by midazolam remain elusive. Herein, using pharmacology, optogenetics, chemogenetics, fiber photometry, and gene knockdown, this in vivo research revealed the role of locus coeruleus (LC)-ventrolateral preoptic nucleus noradrenergic neural circuit in regulating midazolam-induced altered consciousness. This effect was mediated by α1 adrenergic receptors. Moreover, gamma-aminobutyric acid receptor type A (GABAA-R) represents a mechanistically crucial binding site in the LC for midazolam. These findings will provide novel insights into the neural circuit mechanisms underlying the recovery of consciousness after midazolam administration and will help guide the timing of clinical dosing and propose effective intervention targets for timely recovery from midazolam-induced loss of consciousness.
-
- Neuroscience
Gamma oscillations in brain activity (30–150 Hz) have been studied for over 80 years. Although in the past three decades significant progress has been made to try to understand their functional role, a definitive answer regarding their causal implication in perception, cognition, and behavior still lies ahead of us. Here, we first review the basic neural mechanisms that give rise to gamma oscillations and then focus on two main pillars of exploration. The first pillar examines the major theories regarding their functional role in information processing in the brain, also highlighting critical viewpoints. The second pillar reviews a novel research direction that proposes a therapeutic role for gamma oscillations, namely the gamma entrainment using sensory stimulation (GENUS). We extensively discuss both the positive findings and the issues regarding reproducibility of GENUS. Going beyond the functional and therapeutic role of gamma, we propose a third pillar of exploration, where gamma, generated endogenously by cortical circuits, is essential for maintenance of healthy circuit function. We propose that four classes of interneurons, namely those expressing parvalbumin (PV), vasointestinal peptide (VIP), somatostatin (SST), and nitric oxide synthase (NOS) take advantage of endogenous gamma to perform active vasomotor control that maintains homeostasis in the neuronal tissue. According to this hypothesis, which we call GAMER (GAmma MEdiated ciRcuit maintenance), gamma oscillations act as a ‘servicing’ rhythm that enables efficient translation of neural activity into vascular responses that are essential for optimal neurometabolic processes. GAMER is an extension of GENUS, where endogenous rather than entrained gamma plays a fundamental role. Finally, we propose several critical experiments to test the GAMER hypothesis.
